Protopic - Important Safety Information from Astellas Pharma Co. Ltd. as approved by the Irish Medicines Board

Notice type: 3rd Party Publications

Date: 16/02/2010

 

Problem Or Issue:
Important Safety Information communication from Astellas Pharma Co. Ltd. on PROTOPIC ointment1 and recommendations for monitoring with maintenance treatment.

Important Safety Information - Protopic

1Containing 0.03% tacrolimus or 0.1% tacrolimus


« Back